Akt can inhibit the eukaryotic translation initiation factor 4E-binding protein 1(4E-BP1) and upregulate the CBP/p300- interacting transactivator with ED-richcarboxy-terminal domain 4 (CITED4) to enhance cardiac hypertrophy [6,7]. The gene discussed is AKT1; the disease is cardiac hypertrophy.